Cargando…

Chitotriosidase, a biomarker of amyotrophic lateral sclerosis, accentuates neurodegeneration in spinal motor neurons through neuroinflammation

BACKGROUND: Cerebrospinal fluid from amyotrophic lateral sclerosis patients (ALS-CSF) induces neurodegenerative changes in motor neurons and gliosis in sporadic ALS models. Search for identification of toxic factor(s) in CSF revealed an enhancement in the level and enzyme activity of chitotriosidase...

Descripción completa

Detalles Bibliográficos
Autores principales: Varghese, Anu Mary, Ghosh, Mausam, Bhagat, Savita Kumari, Vijayalakshmi, K., Preethish-Kumar, Veeramani, Vengalil, Seena, Chevula, Pradeep-Chandra-Reddy, Nashi, Saraswati, Polavarapu, Kiran, Sharma, Meenakshi, Dhaliwal, Rupinder Singh, Philip, Mariamma, Nalini, Atchayaram, Alladi, Phalguni Anand, Sathyaprabha, Talakad N., Raju, Trichur R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7412641/
https://www.ncbi.nlm.nih.gov/pubmed/32762702
http://dx.doi.org/10.1186/s12974-020-01909-y
_version_ 1783568651829379072
author Varghese, Anu Mary
Ghosh, Mausam
Bhagat, Savita Kumari
Vijayalakshmi, K.
Preethish-Kumar, Veeramani
Vengalil, Seena
Chevula, Pradeep-Chandra-Reddy
Nashi, Saraswati
Polavarapu, Kiran
Sharma, Meenakshi
Dhaliwal, Rupinder Singh
Philip, Mariamma
Nalini, Atchayaram
Alladi, Phalguni Anand
Sathyaprabha, Talakad N.
Raju, Trichur R.
author_facet Varghese, Anu Mary
Ghosh, Mausam
Bhagat, Savita Kumari
Vijayalakshmi, K.
Preethish-Kumar, Veeramani
Vengalil, Seena
Chevula, Pradeep-Chandra-Reddy
Nashi, Saraswati
Polavarapu, Kiran
Sharma, Meenakshi
Dhaliwal, Rupinder Singh
Philip, Mariamma
Nalini, Atchayaram
Alladi, Phalguni Anand
Sathyaprabha, Talakad N.
Raju, Trichur R.
author_sort Varghese, Anu Mary
collection PubMed
description BACKGROUND: Cerebrospinal fluid from amyotrophic lateral sclerosis patients (ALS-CSF) induces neurodegenerative changes in motor neurons and gliosis in sporadic ALS models. Search for identification of toxic factor(s) in CSF revealed an enhancement in the level and enzyme activity of chitotriosidase (CHIT-1). Here, we have investigated its upregulation in a large cohort of samples and more importantly its role in ALS pathogenesis in a rat model. METHODS: CHIT-1 level in CSF samples from ALS (n = 158), non-ALS (n = 12) and normal (n = 48) subjects were measured using ELISA. Enzyme activity was also assessed (ALS, n = 56; non-ALS, n = 10 and normal-CSF, n = 45). Recombinant CHIT-1 was intrathecally injected into Wistar rat neonates. Lumbar spinal cord sections were stained for Iba1, glial fibrillary acidic protein and choline acetyl transferase to identify microglia, astrocytes and motor neurons respectively after 48 h of injection. Levels of tumour necrosis factor-α and interleukin-6 were measured by ELISA. FINDINGS: CHIT-1 level in ALS-CSF samples was increased by 20-fold and it can distinguish ALS patients with a sensitivity of 87% and specificity of 83.3% at a cut off level of 1405.43 pg/ml. Enzyme activity of CHIT-1 was also 15-fold higher in ALS-CSF and has a sensitivity of 80.4% and specificity of 80% at cut off value of 0.1077989 μmol/μl/min. Combining CHIT-1 level and activity together gave a positive predictive value of 97.78% and negative predictive value of 100%. Administration of CHIT-1 increased microglial numbers and astrogliosis in the ventral horn with a concomitant increase in the levels of pro-inflammatory cytokines. Amoeboid-shaped microglial and astroglial cells were also present around the central canal. CHIT-1 administration also resulted in the reduction of motor neurons. CONCLUSIONS: CHIT-1, an early diagnostic biomarker of sporadic ALS, activates glia priming them to attain a toxic phenotype resulting in neuroinflammation leading to motor neuronal death.
format Online
Article
Text
id pubmed-7412641
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-74126412020-08-10 Chitotriosidase, a biomarker of amyotrophic lateral sclerosis, accentuates neurodegeneration in spinal motor neurons through neuroinflammation Varghese, Anu Mary Ghosh, Mausam Bhagat, Savita Kumari Vijayalakshmi, K. Preethish-Kumar, Veeramani Vengalil, Seena Chevula, Pradeep-Chandra-Reddy Nashi, Saraswati Polavarapu, Kiran Sharma, Meenakshi Dhaliwal, Rupinder Singh Philip, Mariamma Nalini, Atchayaram Alladi, Phalguni Anand Sathyaprabha, Talakad N. Raju, Trichur R. J Neuroinflammation Research BACKGROUND: Cerebrospinal fluid from amyotrophic lateral sclerosis patients (ALS-CSF) induces neurodegenerative changes in motor neurons and gliosis in sporadic ALS models. Search for identification of toxic factor(s) in CSF revealed an enhancement in the level and enzyme activity of chitotriosidase (CHIT-1). Here, we have investigated its upregulation in a large cohort of samples and more importantly its role in ALS pathogenesis in a rat model. METHODS: CHIT-1 level in CSF samples from ALS (n = 158), non-ALS (n = 12) and normal (n = 48) subjects were measured using ELISA. Enzyme activity was also assessed (ALS, n = 56; non-ALS, n = 10 and normal-CSF, n = 45). Recombinant CHIT-1 was intrathecally injected into Wistar rat neonates. Lumbar spinal cord sections were stained for Iba1, glial fibrillary acidic protein and choline acetyl transferase to identify microglia, astrocytes and motor neurons respectively after 48 h of injection. Levels of tumour necrosis factor-α and interleukin-6 were measured by ELISA. FINDINGS: CHIT-1 level in ALS-CSF samples was increased by 20-fold and it can distinguish ALS patients with a sensitivity of 87% and specificity of 83.3% at a cut off level of 1405.43 pg/ml. Enzyme activity of CHIT-1 was also 15-fold higher in ALS-CSF and has a sensitivity of 80.4% and specificity of 80% at cut off value of 0.1077989 μmol/μl/min. Combining CHIT-1 level and activity together gave a positive predictive value of 97.78% and negative predictive value of 100%. Administration of CHIT-1 increased microglial numbers and astrogliosis in the ventral horn with a concomitant increase in the levels of pro-inflammatory cytokines. Amoeboid-shaped microglial and astroglial cells were also present around the central canal. CHIT-1 administration also resulted in the reduction of motor neurons. CONCLUSIONS: CHIT-1, an early diagnostic biomarker of sporadic ALS, activates glia priming them to attain a toxic phenotype resulting in neuroinflammation leading to motor neuronal death. BioMed Central 2020-08-06 /pmc/articles/PMC7412641/ /pubmed/32762702 http://dx.doi.org/10.1186/s12974-020-01909-y Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Varghese, Anu Mary
Ghosh, Mausam
Bhagat, Savita Kumari
Vijayalakshmi, K.
Preethish-Kumar, Veeramani
Vengalil, Seena
Chevula, Pradeep-Chandra-Reddy
Nashi, Saraswati
Polavarapu, Kiran
Sharma, Meenakshi
Dhaliwal, Rupinder Singh
Philip, Mariamma
Nalini, Atchayaram
Alladi, Phalguni Anand
Sathyaprabha, Talakad N.
Raju, Trichur R.
Chitotriosidase, a biomarker of amyotrophic lateral sclerosis, accentuates neurodegeneration in spinal motor neurons through neuroinflammation
title Chitotriosidase, a biomarker of amyotrophic lateral sclerosis, accentuates neurodegeneration in spinal motor neurons through neuroinflammation
title_full Chitotriosidase, a biomarker of amyotrophic lateral sclerosis, accentuates neurodegeneration in spinal motor neurons through neuroinflammation
title_fullStr Chitotriosidase, a biomarker of amyotrophic lateral sclerosis, accentuates neurodegeneration in spinal motor neurons through neuroinflammation
title_full_unstemmed Chitotriosidase, a biomarker of amyotrophic lateral sclerosis, accentuates neurodegeneration in spinal motor neurons through neuroinflammation
title_short Chitotriosidase, a biomarker of amyotrophic lateral sclerosis, accentuates neurodegeneration in spinal motor neurons through neuroinflammation
title_sort chitotriosidase, a biomarker of amyotrophic lateral sclerosis, accentuates neurodegeneration in spinal motor neurons through neuroinflammation
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7412641/
https://www.ncbi.nlm.nih.gov/pubmed/32762702
http://dx.doi.org/10.1186/s12974-020-01909-y
work_keys_str_mv AT vargheseanumary chitotriosidaseabiomarkerofamyotrophiclateralsclerosisaccentuatesneurodegenerationinspinalmotorneuronsthroughneuroinflammation
AT ghoshmausam chitotriosidaseabiomarkerofamyotrophiclateralsclerosisaccentuatesneurodegenerationinspinalmotorneuronsthroughneuroinflammation
AT bhagatsavitakumari chitotriosidaseabiomarkerofamyotrophiclateralsclerosisaccentuatesneurodegenerationinspinalmotorneuronsthroughneuroinflammation
AT vijayalakshmik chitotriosidaseabiomarkerofamyotrophiclateralsclerosisaccentuatesneurodegenerationinspinalmotorneuronsthroughneuroinflammation
AT preethishkumarveeramani chitotriosidaseabiomarkerofamyotrophiclateralsclerosisaccentuatesneurodegenerationinspinalmotorneuronsthroughneuroinflammation
AT vengalilseena chitotriosidaseabiomarkerofamyotrophiclateralsclerosisaccentuatesneurodegenerationinspinalmotorneuronsthroughneuroinflammation
AT chevulapradeepchandrareddy chitotriosidaseabiomarkerofamyotrophiclateralsclerosisaccentuatesneurodegenerationinspinalmotorneuronsthroughneuroinflammation
AT nashisaraswati chitotriosidaseabiomarkerofamyotrophiclateralsclerosisaccentuatesneurodegenerationinspinalmotorneuronsthroughneuroinflammation
AT polavarapukiran chitotriosidaseabiomarkerofamyotrophiclateralsclerosisaccentuatesneurodegenerationinspinalmotorneuronsthroughneuroinflammation
AT sharmameenakshi chitotriosidaseabiomarkerofamyotrophiclateralsclerosisaccentuatesneurodegenerationinspinalmotorneuronsthroughneuroinflammation
AT dhaliwalrupindersingh chitotriosidaseabiomarkerofamyotrophiclateralsclerosisaccentuatesneurodegenerationinspinalmotorneuronsthroughneuroinflammation
AT philipmariamma chitotriosidaseabiomarkerofamyotrophiclateralsclerosisaccentuatesneurodegenerationinspinalmotorneuronsthroughneuroinflammation
AT naliniatchayaram chitotriosidaseabiomarkerofamyotrophiclateralsclerosisaccentuatesneurodegenerationinspinalmotorneuronsthroughneuroinflammation
AT alladiphalgunianand chitotriosidaseabiomarkerofamyotrophiclateralsclerosisaccentuatesneurodegenerationinspinalmotorneuronsthroughneuroinflammation
AT sathyaprabhatalakadn chitotriosidaseabiomarkerofamyotrophiclateralsclerosisaccentuatesneurodegenerationinspinalmotorneuronsthroughneuroinflammation
AT rajutrichurr chitotriosidaseabiomarkerofamyotrophiclateralsclerosisaccentuatesneurodegenerationinspinalmotorneuronsthroughneuroinflammation